title: [Male urinary incontinence].
abstract: *Urinary incontinence in males is gaining increasingly more attention. *Male urinary incontinence can be classified as storage incontinence due to overactive bladder syndrome or stress incontinence due to urethral sphincter dysfunction. *Most patients benefit from the currently available treatment options for overactive bladder, which include physiotherapy, medication, botulinum A toxin injections and neuromodulation techniques. *The number of radical prostatectomies performed for prostate cancer is increasing; this intervention can lead to stress incontinence due to sphincter weakness. *Various treatment options are available for stress incontinence due to sphincter weakness. *In addition to physiotherapy, treatment options also include the artificial urinary sphincter, which has been available for decades. *New treatments include para-urethral balloons and male slings. The value of these approaches must be proven in the coming years.
authors.affiliation: Universitair Medisch Centrum St Radboud, afd. Urologie, Nijmegen.
authors.forename: T A
authors.initials: TA
authors.lastname: de Boer
authors.forename: J P F A
authors.initials: JP
authors.lastname: Heesakkers
mesh_terms: D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D053201:Urinary Bladder, Overactive; D014549:Urinary Incontinence / Q000453:epidemiology / Q000601:surgery / Q000628:therapy*; D014550:Urinary Incontinence, Stress / Q000453:epidemiology / Q000601:surgery / Q000628:therapy*; D053202:Urinary Incontinence, Urge / Q000453:epidemiology / Q000601:surgery / Q000628:therapy*; D016741:Urinary Sphincter, Artificial
chemical_list: D019274:Botulinum Toxins, Type A